Skip to content

Effect of Ayurveda Medication in Heart Disease

The Efficacy Of Yapana Basti In Coronary Artery Disease(Hridroga).

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/07/015015
Enrollment
15
Registered
2018-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Symptoms of CAD. Known case of CAD. Age between 30-60yrs. Fit for Basti.

Interventions

Intervention1: Yapana Basti: Drug Bala Atibala Rasna Aragwadh Madanphala Bilwa Guduchi Punarnava Eranda Ashwaganda Sahachara Palash Devdaru Agnimantha Shyonaka Patla Gambhari Gokshur

Sponsors

KAHERs Shri B M Kankanawadi Ayurveda Mahavidyalaya
Lead Sponsor
Dr Rushikesh Tejrao Dahake
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Symptoms of CAD. Known case of CAD. Age between 30-60yrs. Fit for Basti.

Exclusion criteria

Exclusion criteria: CAD with Cardio Myopathy Valve wall heart defect. CCF.

Design outcomes

Primary

MeasureTime frame
Yapan basti is efficacious in treating sings and symptoms of Coronary artery disease more efficiently.Timepoint: 1st, 8th, 16th day

Secondary

MeasureTime frame
Not ApplivableTimepoint: Not Applivable

Countries

India

Contacts

Public ContactDr Rajshekar Sanpeti

KAHERs Shri B M Kankanawadi Ayurveda Mahavidyalaya

rushidahake123@gmail.com9730852824

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026